Female breast cancer incidence and mortality in China, 2013-Reference-Cited by-同舟云学术

Female breast cancer incidence and mortality in China, 2013

Published:2017-03-13 Issue:3 Volume:8 Page:214-218
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Zuo Ting-Ting¹,Zheng Rong-Shou¹,Zeng Hong-Mei¹,Zhang Si-Wei¹,Chen Wan-Qing¹

Affiliation:

1. National Office for Cancer Prevention and Control, National Cancer Center/Cancer Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

Funder

Natural Science Foundation of Beijing Municipality

Ministry of Science and Technology

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12426/fullpdf

Reference15 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Female breast cancer statistics of 2010 in China: Estimates based on data from 145 population-based cancer registries;Zeng;J Thorac Dis,2014

3. Female breast cancer incidence and mortality in 2011, China;Jia;J Thorac Dis,2015

4. Study on risk factors of breast cancer among urban women in China;Wang;Zhonghua Liu Xing Bing Xue Za Zhi,2000

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR‐600 mediates EZH2/RUNX3 signal axis to modulate breast cancer cell viability and sorafenib sensitivity;Journal of Biochemical and Molecular Toxicology;2023-12-21

2. Semi-supervised breast cancer pathology image segmentation based on fine-grained classification guidance;Medical & Biological Engineering & Computing;2023-12-12

3. Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries;Asia-Pacific Journal of Clinical Oncology;2023-04-07

4. Oncology nurses' and oncologists’ experience of addressing sexual health concerns in breast cancer patients: A qualitative study;European Journal of Oncology Nursing;2023-04

5. PD‑L1 mediates triple‑negative breast cancer evolution via the regulation of TAM/M2 polarization;International Journal of Oncology;2022-10-17